FDA Approvals

FDA Approves Avycaz for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

10th February 2018

Allergan plc , a leading global pharmaceutical company, announced that the U.S. FDA has approved Allergan's supplemental New Drug Application...

GSK’S B vaccine prevents harmful disease among children; U.S FDA applauds

by Content Team

9th February 2018

GlaxoSmithKline plc announced that it has received Breakthrough Therapy Designation from the U.S. FDA for its meningitis B vaccine Bexsero...

BioProtect begins study of ProSpace biodegradable spacer to protect rectum, lower GI tract during radiation therapy

by Content Team

11th January 2018

BioProtect, the technology leader in biodegradable balloon spacers protecting normal tissue during radiation therapy, announced the launch of its clinical...

Novo Nordisk Receives FDA Approval Of OZEMPIC® (Semaglutide) Injection For The Treatment Of Adults With Type 2 Diabetes

by Yuvraj_pawp

6th December 2017

Novo Nordisk Receives FDA Approval Of OZEMPIC® (Semaglutide) Injection For The Treatment Of Adults With Type 2 Diabetes

Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for OZEMPIC® (semaglutide)...

Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD

by Yuvraj_pawp

5th December 2017

Sunovion Pharmaceuticals Inc announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for Lonhala™...

Merck’s Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada

by Yuvraj_pawp

4th December 2017

Merck, a leading science and technology company, today announced that Health Canada has approved MAVENCLAD™ (Cladribine Tablets) as monotherapy for...

FDA Approves Amgen’s Repatha® (evolocumab) To Prevent Heart Attack And Stroke

by Yuvraj_pawp

4th December 2017

Amgen announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug Administration (FDA) approved...

FDA grants orphan drug status to Shire’s UC treatment SHP647

by Yuvraj_pawp

1st December 2017

The US Food and Drug Administration (FDA) has granted orphan drug designation to Shire’s investigational mucosal addressin cell adhesion molecule-1...